Skip to main content
Log in

Compatibility study of rivaroxaban and its pharmaceutical excipients

  • Published:
Journal of Thermal Analysis and Calorimetry Aims and scope Submit manuscript

Abstract

Rivaroxaban is an oral direct Factor Xa inhibitor to treat thrombus. The aim of this study is to investigate the drug–excipient compatibility between rivaroxaban tablet and pharmaceutical excipients by a combination of thermal and spectroscopic methods. Differential scanning calorimetry (DSC) is the most important technique to evaluate the compatibility. In addition, X-ray powder diffraction (XRPD) is a complementary technique to explain the DSC result and exclude relevant interaction. On the basis of DSC curves about rivaroxaban and excipient and mixture (1:1, w/w), the rivaroxaban was considered to be compatible with the most excipients (microcrystalline cellulose, lactose, hydroxyl propyl methyl cellulose, magnesium stearate). Meanwhile, the XRPD studies also showed the compatibility of rivaroxaban and pharmaceutical excipients, especially for the sodium lauryl sulfate. Overall, the compatibility of the excipients with rivaroxaban was assessed successfully by DSC and XRPD, and the formulations developed using the compatible excipient were found to be stable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Kubitza DD, Becka DM, Mueck DW, et al. Safety, tolerability, pharmacodynamics, and pharmacokinetics of Rivaroxaban-an oral, direct factor Xa inhibitor-are not affected by Aspirin. J Clin Pharmacol. 2006;46:981–90.

    Article  CAS  Google Scholar 

  2. Roehrig S, Straub A, Pohlmann J, et al. Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-ylmethyl)thiophene-2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor. J Med Chem. 2005;48:5900–8.

    Article  CAS  Google Scholar 

  3. Grunenberg A, Fähnrich K, Queckenberg O, et al. Co-crystal compound of rivaroxaban and malonic acid. US, US 8466280 B2. 2013.

  4. Li DX, Ke H, Fan XB, et al. A new crystal form of rivaroxaban and preparation method and use. CN, CN104211693A. 2014.

  5. Gamini V, Prabhudas B. Polymorphic form of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl) phenyl]-1, 3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide. CN, CN102292332 A. 2011.

  6. Gao R, Jin Y, Yang QY, et al. Study of stability and drug–excipient compatibility of estradiol and pharmaceutical excipients. J Therm Anal Calorim. 2015;120:839–45.

    Article  CAS  Google Scholar 

  7. Matos APS, Costa JS, Boniatti J, et al. Compatibility study between diazepam and tablet excipients. J Therm Anal Calorim. 2016; 1–8.

  8. Gao R, Sun BW, Lin J, et al. Compatibility of medroxyprogesterone acetate and pharmaceutical excipients through thermal and spectroscopy techniques. J Therm Anal Calorim. 2014;117:731–9.

    Article  CAS  Google Scholar 

  9. Narang AS, Yamniuk A, Zhang L, et al. Drug excipient interactions. In: AS Narang, SHS Boddu, editors. Excipient applications in formulation design and drug delivery. Springer; 2015. p. 13–35.

  10. Wang Y, Luo YH, Zhao J, Sun BW. Selection of excipients for dispersible tablets of itraconazole through the application of thermal techniques and Raman spectroscopy. J Therm Anal Calorim. 2013;115:2391–400.

    Article  Google Scholar 

  11. Luo YH, Wen GJ, Gu LS, et al. Study of spin crossover in an iron(II) tris(diimine) system tuned by counter anions. Polyhedron. 2017;121:101–6.

    Article  CAS  Google Scholar 

  12. Luo YH, Wu DE, Wen GJ, et al. A two-dimensional supramolecular ice layer containing “Quasi-Chair” (H2 O)6 hexagons templated by organic carboxylic host. ChemistrySelect. 2017;2:61–4.

    Article  CAS  Google Scholar 

  13. Stulzer HK, Rodrigues PO, Cardoso TM, et al. Compatibility studies between captopril and pharmaceutical excipients used in tablets formulations. J Therm Anal Calorim. 2008;91:323–8.

    Article  CAS  Google Scholar 

  14. Groom Nanboge A, Lentz J, Braun GA, Kell B, Thomas CR. New crystal forms and amorphous form of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl) phenyl]-1, 3-oxazolidin-5-ylmethyl) thiophene-2-carboxamide. Publish No: CN101282968.

  15. Kandarapu R, Grover V, Chawla HPS, et al. Evaluation of compatibility of ketorolac tromethamine with selected polymers and common tablet excipients by thermal and isothermal stress testing. Stp Pharma Sci. 2001;11:449–57.

    CAS  Google Scholar 

  16. Mura P, Manderioli A, Bramanti G, et al. Utilization of differential scanning calorimetry as a screening technique to determine the compatibility of ketoprofen with excipients. Int J Pharm. 1995;119:71–9.

    Article  CAS  Google Scholar 

  17. Araújo AAS, Storpirtis S, Mercuri LP, et al. Thermal analysis of the antiretroviral zidovudine (AZT) and evaluation of the compatibility with excipients used in solid dosage forms[J]. Int J Pharm. 2003;260:303–14.

    Article  Google Scholar 

  18. Lima NGPB, Lima IPB, Barros DMC, et al. Compatibility studies of trioxsalen with excipients by DSC, DTA, and FTIR. J Therm Anal Calorim. 2014;115:2311–8.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This research was based on work supported by the Technological Program Foundation of Jiangsu Province (No. BY2015070-09) and PAPD of Jiangsu Higher Education Institutions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bai-Wang Sun.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ding, T., Chen, L., Zhai, LH. et al. Compatibility study of rivaroxaban and its pharmaceutical excipients. J Therm Anal Calorim 130, 1569–1573 (2017). https://doi.org/10.1007/s10973-017-6412-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10973-017-6412-3

Keywords

Navigation